Search
Home
SiteMap
About Us
Case Studies
Testimonials
Playlists
×
Read More
Copy Link
Share On
Diabetes & Heart Health Breakthrough
New real-world data confirms that the diabetes and weight-loss medications Ozempic (semaglutide) and Mounjaro (tirzepatide) offer powerful cardiovascular protection. A study found these drugs significantly reduce the risk of major events like strokes and heart attacks in patients with Type 2 diabetes, demonstrating benefits beyond simple blood sugar control. This finding marks a major shift in diabetes care.
« Prev
Know More
Share
Install on your device for quick access.
Install
Dismiss
